div class="flex max-w-full flex-col grow">Pathologists (Freelance - Remote).
We've built a unique platform that connects researchers and companies with a global pool of participants, enabling the collection of high-quality, ethically sourced human behavioural data and feedback.
div class="flex max-w-full flex-col grow">Cardiologists (Freelance - Remote).
We've built a unique platform that connects researchers and companies with a global pool of participants, enabling the collection of high-quality, ethically sourced human behavioural data and feedback.
Webcam participation is expected during all instructor‑led TTEC and client‑required training, either throughout the session or at designated times, and is encouraged during coaching sessions to support meaningful connection and collaboration. Whether it’s getting answers for customers quickly, consulting on products with compassion or resolving their issues with a smile, you’ll be the difference between their customer experience being just average or an exceptional one.
Collect, track, and file essential regulatory documents including FDA Forms 1572, financial disclosure forms, protocol amendments, IRB approvals, and sponsor correspondence - all managed remotely via electronic platforms. Communicate regularly with on-site study staff, the Principal Investigator, and sponsor/CRO representatives via email, phone, and video conference to ensure document accuracy and completeness.
Core Requirements for Candidacy: We are looking for elite clinicians who meet the following strict criteria: Current, unrestricted license to practice as a Clinical Psychologist in the U.S. Proven expertise in delivering therapy and assessments effectively in a virtual format. Financial Reliability: Enjoy guaranteed income stability—you are paid for every session booked, including last-minute cancellations and no-shows.
Key aspects of this role will include engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and provide support for medical education, advisory boards, and medical congresses. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.